Population Pharmacokinetic and Pharmacodynamic Modeling Analysis of GCC‐4401C, a Novel Direct Factor Xa Inhibitor, in Healthy Volunteers

Por Choi, HY, Choi, S, Kim, YH, Lim, HS
Publicado no CPT Pharmacometrics Syst Pharmacol (2016)

Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers

Por Kim H, Choi HY, Kim YH, Bae KS, Jung J, Son H, Lim HS
Publicado em 2018-04-01

Single and multiple dose pharmacokinetics and tolerability of HX-1171, a novel antioxidant, in healthy volunteers

Por Kim YH, Choi HY, Lee SH, Lim HS, Miki T, Kang JK, Han KG, Bae KS
Publicado em 2015-03-01

Is Empirical Four Pulmonary Vein Isolation Necessary for Focally Triggered Paroxysmal Atrial Fibrillation? Comparison of Selective Pulmonary Vein Isolation Versus Empirical Four Pu...

Por Pak, H N, Kim, J S, Shin, S Y, Lee, H S, Choi, J I, Lim, H E, Hwang, C, Kim, YH
Publicado no J Atr Fibrillation (2008)

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer

Por Kwei, KA, Kim, YH, Girard, L, Kao, J, Pacyna-Gengelbach, M, Salari, K, Lee, J, Choi, Y-L, Sato, M, Wang, P, Hernandez-Boussard, T, Gazdar, AF, Petersen, I, Minna, JD, Pollack, JR
Publicado em 2008

International models of investigator-initiated trials: implications for Japan

Por Trimble, E. L., Ledermann, J., Law, K., Miyata, T., Imamura, C. K., Nam, B.-H., Kim, Y.H., Bang, Y.-J., Michaels, M., Ardron, D., Amano, S., Ando, Y., Tominaga, T., Kurokawa, K., Takebe, N.
Publicado em 2012